Baidu
map

阴茎癌眼部转移一例

2018-03-17 佚名 中华眼科杂志

患者男性,43岁。因右眼疼痛伴视力下降1个月余,而于2015年1月31日入住皖南医学院附属弋矶山医院眼科。

【一般资料】

患者男性,43岁。

【主诉】

因右眼疼痛伴视力下降1个月余,而于2015年1月31日入住皖南医学院附属弋矶山医院眼科。

【现病史】

2012年11月发现外阴处一黄豆粒大小新生物,位于阴茎包皮处,后龟头变硬,尿道外口溢血伴轻度压痛,外院予包皮环切术及阴茎占位活检术,病理考虑湿疣样变,予CO2冷冻去除疣体及抗病毒治疗;后原位再次出现增生物,行浅表肿物切除术,病理示阴茎癌,2013年7月24日行阴茎癌根治切除术,病理检查结果提示阴茎高分化鳞癌,浸润肌层;后复查发现双侧腹股沟肿物,行双侧腹股沟淋巴结清扫术。以后又因左侧大腿根部皮下软组织、双侧腹股沟及髂血管旁淋巴结转移,于2014年9月29日行左下肢血管探查+带蒂肌皮瓣切除移植+左髋关节周围骨骼肌软组织肿瘤切除+腹股沟淋巴结清扫术。2015年1月13日患者因出现右眼视力下降而首次就诊眼科,MRI平扫提示右眼脉络膜转移癌。建议进一步检查,患者拒绝,后因右眼视力丧失伴眼球剧烈疼痛而入院。

【体格检查】

神志清楚,精神可,自主体位,跛行,消瘦体型,右腹股沟处及右大腿见陈旧性手术瘢痕,双肺呼吸音粗,双下肢无水肿。眼科检查:右眼无光感,左眼1.0,眼压(非接触式眼压计):右眼13.0mmHg(1mmHg=0.133kPa),左眼11.0mmHg,右眼球轻度突出,眼位居中,各方向活动度正常,角膜透明,前房深浅可,房水清,瞳孔圆,直径5mm,光反射消失,晶状体轻度混浊,玻璃体混浊,眼底视盘边界欠清,色淡,后极部视网膜下黑色隆起,视网膜脱离;左眼未见明显异常。

【辅助检查】

眼部B超示右眼球占位(考虑转移灶可能)。眼眶MRI示右侧视网膜脱离并出血,眼球外侧环壁增厚强化(图1~3)



【初步诊断

诊断为右眼球转移癌。

【治疗】

2015年2月3日在全身麻醉下行右眼球摘除术,术中见眼球完整,内、外直肌均增厚变硬,视神经增粗,长约2cm,残端受侵犯。病理检查提示眼球部转移癌(高分化鳞癌),浸润巩膜、脉络膜、视网膜、视神经及眼外(图4~6)。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1776065, encodeId=3a3b1e7606541, content=<a href='/topic/show?id=508ae2913d6' target=_blank style='color:#2F92EE;'>#眼部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72913, encryptionId=508ae2913d6, topicName=眼部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=126338864246, createdName=huiwelcome, createdTime=Thu Nov 15 04:34:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297740, encodeId=9c1729e740bd, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Mon Mar 19 15:10:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293895, encodeId=9b2712938957a, content=<a href='/topic/show?id=bdf29e54396' target=_blank style='color:#2F92EE;'>#阴茎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97543, encryptionId=bdf29e54396, topicName=阴茎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Mar 19 00:34:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528197, encodeId=b116152819eb4, content=<a href='/topic/show?id=62ca9e55940' target=_blank style='color:#2F92EE;'>#阴茎癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97559, encryptionId=62ca9e55940, topicName=阴茎癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a511911925, createdName=waiwai3034, createdTime=Mon Mar 19 00:34:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297073, encodeId=dd9429e07343, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Mar 17 10:05:59 CST 2018, time=2018-03-17, status=1, ipAttribution=)]
    2018-11-15 huiwelcome
  2. [GetPortalCommentsPageByObjectIdResponse(id=1776065, encodeId=3a3b1e7606541, content=<a href='/topic/show?id=508ae2913d6' target=_blank style='color:#2F92EE;'>#眼部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72913, encryptionId=508ae2913d6, topicName=眼部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=126338864246, createdName=huiwelcome, createdTime=Thu Nov 15 04:34:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297740, encodeId=9c1729e740bd, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Mon Mar 19 15:10:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293895, encodeId=9b2712938957a, content=<a href='/topic/show?id=bdf29e54396' target=_blank style='color:#2F92EE;'>#阴茎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97543, encryptionId=bdf29e54396, topicName=阴茎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Mar 19 00:34:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528197, encodeId=b116152819eb4, content=<a href='/topic/show?id=62ca9e55940' target=_blank style='color:#2F92EE;'>#阴茎癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97559, encryptionId=62ca9e55940, topicName=阴茎癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a511911925, createdName=waiwai3034, createdTime=Mon Mar 19 00:34:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297073, encodeId=dd9429e07343, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Mar 17 10:05:59 CST 2018, time=2018-03-17, status=1, ipAttribution=)]
    2018-03-19 飘飘爱

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1776065, encodeId=3a3b1e7606541, content=<a href='/topic/show?id=508ae2913d6' target=_blank style='color:#2F92EE;'>#眼部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72913, encryptionId=508ae2913d6, topicName=眼部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=126338864246, createdName=huiwelcome, createdTime=Thu Nov 15 04:34:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297740, encodeId=9c1729e740bd, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Mon Mar 19 15:10:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293895, encodeId=9b2712938957a, content=<a href='/topic/show?id=bdf29e54396' target=_blank style='color:#2F92EE;'>#阴茎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97543, encryptionId=bdf29e54396, topicName=阴茎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Mar 19 00:34:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528197, encodeId=b116152819eb4, content=<a href='/topic/show?id=62ca9e55940' target=_blank style='color:#2F92EE;'>#阴茎癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97559, encryptionId=62ca9e55940, topicName=阴茎癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a511911925, createdName=waiwai3034, createdTime=Mon Mar 19 00:34:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297073, encodeId=dd9429e07343, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Mar 17 10:05:59 CST 2018, time=2018-03-17, status=1, ipAttribution=)]
    2018-03-19 dingxiaobo
  4. [GetPortalCommentsPageByObjectIdResponse(id=1776065, encodeId=3a3b1e7606541, content=<a href='/topic/show?id=508ae2913d6' target=_blank style='color:#2F92EE;'>#眼部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72913, encryptionId=508ae2913d6, topicName=眼部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=126338864246, createdName=huiwelcome, createdTime=Thu Nov 15 04:34:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297740, encodeId=9c1729e740bd, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Mon Mar 19 15:10:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293895, encodeId=9b2712938957a, content=<a href='/topic/show?id=bdf29e54396' target=_blank style='color:#2F92EE;'>#阴茎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97543, encryptionId=bdf29e54396, topicName=阴茎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Mar 19 00:34:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528197, encodeId=b116152819eb4, content=<a href='/topic/show?id=62ca9e55940' target=_blank style='color:#2F92EE;'>#阴茎癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97559, encryptionId=62ca9e55940, topicName=阴茎癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a511911925, createdName=waiwai3034, createdTime=Mon Mar 19 00:34:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297073, encodeId=dd9429e07343, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Mar 17 10:05:59 CST 2018, time=2018-03-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1776065, encodeId=3a3b1e7606541, content=<a href='/topic/show?id=508ae2913d6' target=_blank style='color:#2F92EE;'>#眼部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72913, encryptionId=508ae2913d6, topicName=眼部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=126338864246, createdName=huiwelcome, createdTime=Thu Nov 15 04:34:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297740, encodeId=9c1729e740bd, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Mon Mar 19 15:10:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293895, encodeId=9b2712938957a, content=<a href='/topic/show?id=bdf29e54396' target=_blank style='color:#2F92EE;'>#阴茎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97543, encryptionId=bdf29e54396, topicName=阴茎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Mon Mar 19 00:34:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528197, encodeId=b116152819eb4, content=<a href='/topic/show?id=62ca9e55940' target=_blank style='color:#2F92EE;'>#阴茎癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97559, encryptionId=62ca9e55940, topicName=阴茎癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a511911925, createdName=waiwai3034, createdTime=Mon Mar 19 00:34:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297073, encodeId=dd9429e07343, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat Mar 17 10:05:59 CST 2018, time=2018-03-17, status=1, ipAttribution=)]
    2018-03-17 龙胆草

    学习谢谢分享

    0

相关资讯

Dermatol Surg:阴茎癌?考虑下Mohs显微外科手术呗

根据最近发表的研究数据,对于阴茎鳞状细胞癌,Mohs显微外科手术在保护组织的情况下提供了高治愈率,或许可以替代其他切除技术。研究人员对42名白种人患者进行了一项回顾性研究,涉及44例阴茎鳞状细胞癌(SCC),患者手术时的平均年龄为64.4岁。39%的肿瘤主要位于龟头,41%的在阴茎体,14%的在阴茎根部包,还有4.5%的在包皮上。其中48例通过Mohs显微外科手术(MMS)治疗,包括44例首次MM

2016NCCN临床实践指南——阴茎癌-证据块(2016.V2)发布

2016年8月26日,美国国家综合癌症网络(NCCN)发布了阴茎癌证据块2016年第2版。全文获取:下载地址:指南下载 (需要扣积分2分, 梅斯医学APP免积分下载) 

NCCN临床实践指南:阴茎癌(2018.V1)

2018年1月,美国国家综合癌症网络(NCCN)发布了阴茎癌指南2018年第1版,指南主要内容涉及: 指南更新摘要 初级评估,临床诊断 Tis,Ta期疾病初级治疗 T1,T2或更晚期疾病初级治疗 不明显腹股沟淋巴结的管理 体积不大的腹股沟淋巴结的管理 体积较大的腹股沟淋巴结的管理 巨大腹股沟淋巴结的管理 监测时间表 复发性疾病的管理 转移性疾病的管控 手术治疗原则 放射治疗原则 化疗原则 疾病分期

BMC Cancer:阴茎癌淋巴结外转移预示更差的预后

研究者进行了一项荟萃分析,调查阴茎癌淋巴结外侵犯 (ENE)评估预后的重要性,以及阴茎癌患者盆腔淋巴结转移(PLNM) 情况。研究者检索了Medline、Embase、Cochrane Library、Scopus等数据库,最终纳入了1142名患者进行荟萃分析。分析数据显示,ENE患者与非ENE患者相比,癌症特异性生存(CSS)更差(HR = 1.90, 95 % CI = 1.35-2.67,

必看丨HPV和肿瘤君的爱恨情仇,宫颈癌地位岌岌可危

近日美国疾病预防控制中心(CDC)发布的数据显示,从2008年到2012年,在美国每年大约有39000例HPV相关的癌症被诊断。近29000例HPV相关癌症可以通过接种HPV疫苗进行预防。这句话里有几个需要弄明白的信息,什么HPV?与HPV相关的癌症有哪些?最后的关键肯定是如何去预防。对HPV做个简单介绍:人乳头瘤病毒( human papillomavirus,HPV) 是一组嗜上皮组织双链

Sci Rep:多维整体分析揭示了阴茎癌驱使候选因子和生物标记

阴茎癌(PeCa)在贫穷和不发达国家中是一个显著的公共健康问题,分子数据生成和它们在阴茎癌(PeCa)中的结合仍旧没有很好的研究。最近,有研究人员利用整体方法学结合基因组范围的拷贝数变异、DNA甲基化、miRNA和mRNA表达分析对20名普通PeCa患者进行了研究分析。研究发现,排名前16个驱使候选因子具有基因组变异并且受一系列的miRNAs调控,包括了hsa-miR-31, hsa-miR-34

Baidu
map
Baidu
map
Baidu
map